Evidence map›Paper›PMID 36012730›Full record

ReviewInternational journal of molecular sciences2022

Current Status of the Diagnosis and Management of Osteoporosis.

Agustín Aibar-Almazán, Ana Voltes-Martínez, Yolanda Castellote-Caballero, Diego Fernando Afanador-Restrepo, María Del Carmen Carcelén-Fraile, Elena López-Ruiz

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 239 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
239citing papers in PubMed, 8 pooled it
62.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

239 citing papers in PubMed, 8 syntheses or guidelines pooled it, 360 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

179 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Agustín Aibar-AlmazánDepartment of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain.ORCID 0000-0002-9386-9199
Ana Voltes-MartínezCentre for Biomedical Research (CIBM), Biopathology and Regenerative Medicine Institute (IBIMER), University of Granada, E-18011 Granada, Spain.
Yolanda Castellote-CaballeroDepartment of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain.ORCID 0000-0002-6233-6787
Diego Fernando Afanador-RestrepoZIPATEFI Research Group, Faculty of Health Sciences and Sports, University Foundation of the Área Andina, Pereira 660001, Colombia.ORCID 0000-0002-7958-0751
María Del Carmen Carcelén-FraileDepartment of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain.
Elena López-RuizDepartment of Health Sciences, Campus de Las Lagunillas SN, University of Jaén, E-23071 Jaén, Spain.
Universidad de Jaén · ESUniversidad de Granada · ES

Funding

The Fundación Mutua Madrileña FMM-AP17196-2019the Operative Program FEDER 2014-2020, the Consejería de Economía y Conocimiento de la Junta de Andalucía 1381650
6 · The paper itself

Abstract

Osteoporosis has been defined as the silent disease of the 21st century, becoming a public health risk due to its severity, chronicity and progression and affecting mainly postmenopausal women and older adults. Osteoporosis is characterized by an imbalance between bone resorption and bone production. It is diagnosed through different methods such as bone densitometry and dual X-rays. The treatment of this pathology focuses on different aspects. On the one hand, pharmacological treatments are characterized by the use of anti-resorptive drugs, as well as emerging regenerative medicine treatments such as cell therapies and the use of bioactive hydrogels. On the other hand, non-pharmacological treatments are associated with lifestyle habits that should be incorporated, such as physical activity, diet and the cessation of harmful habits such as a high consumption of alcohol or smoking. This review seeks to provide an overview of the theoretical basis in relation to bone biology, the existing methods for diagnosis and the treatments of osteoporosis, including the development of new strategies.

Indexed as

Bone ResorptionOsteoporosisOsteoporosis, PostmenopausalAgedBone DensityExerciseFemaleHealth BehaviorHumansSmokinglifestyle habitsosteoporosisregenerative medicine

Identifiers

PMID36012730
PMCPMC9408932
OpenAlexW4293030541

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.